"Lindbergh" SOS: "Lindbergh"-style thoughtfully selected music playing in background...
John Holcombe, Lilly "Diabetes Expert"-1999
"Animal insulin is the Lindbergh of the space shuttle age," said Dr. John H. Holcombe, senior clinical
research physician for diabetes care at Lilly. "It's antiquated."
"Space Shuttle" SOS: Music Video thoughtfully selected below.
Baltimore Sun, August 11, 2006
"When you look at that kind of space-age technology and compare it to an 80-year-old therapy, you can see why the market has changed," said Scott MacGregor, a spokesman for Eli Lilly.
Q: Why hasn't Eli Lilly & Co. stock performed better? It's a big retirement holding of mine.
A: Although the pharmaceutical giant will continue to be a big-time player, its lowered expectations for the rest of this year have taken a toll on its stock.
After previously forecasting 7 percent to 9 percent sales growth for 2006, management now expects results in the lower end of that range. That's due in part to disappointing sales of its insulin drugs.
Baltimore Sun, August 11.2006
Lilly was the last company to produce the animal insulins in North America, but announced last summer it would stop production and focus on its synthetic insulins.
"We estimated that there were fewer than 2,000 patients still using pork insulin," said MacGregor. "This is driven by what's going on in the market and what physicians see as the best therapy."
Lilly "Diabetes Specialists": 'Lindbergh' photo left, on right-'Space Shuttle' photo right
Amazing but true: the SOS, whether it is the "Lindbergh" or "Space Shuttle" version still has the same results: disappointing sales of Lilly insulins--all of them now r-DNA and analog.
If Lilly decisions are driven by the insulin market and by what MD's see as the best therapy, as stated above, why does this translate as a loss of market share?
Reply
Home
bravenet.com
John Holcombe, Lilly "Diabetes Expert"-1999 
